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CHAPTER I 
INTRODUCTICN 
A. Some Aspects of .P,yruvate Metabolism 
Pyruvate, a branch point in the catabolic sequence of glucose (1), 
can enter the tricarboxylic acid cycle in two different ways, by oxi-
dative decarboxylation to acetyl-CoA (2, 3), or by condensation with 
carbon dioxide to form a dicarboxylic acid (4, 5, 6). Pyruvate enter-
ing the TCA cycle as a dicarboxylic·acid yields a net increase in the 
mass of cycle intermediates, and permits their use in synthesis. On 
the other hand, pyruvate entering as acetyl-CoA provides no net increase 
in intermediates but permits the use of the Krebs cycle for energy pur-
poses only. The relative proportion of pyruvate entering the TCA cycle 
by these routes has been estimated by administration of pyruvate-2-c14 
(7) or of DL-alanine-2-cl4 (8) to rats and the determination of the 
relative radioactivity of the individual carbon atoms of tissue L-
glutamic acid. An abbreviated diagram of the TCA cycle is shown in Fig-
ure 1. 
Labeling patterns in glutamic acid have been used to indicate the 
relative amounts of pyruvate converted to acetate and to dicarboxylic 
acids (7, 8). When pyruvate is metabolized by oxidative decarboxylation, 
the resulting acetyl-CoA will be a precursor of carbons 4 and 5 of glu-
tamate, and when pyruvate is metabolized via a dicarboxylic acid, oxal-
acetic acid will be a precursor of carbons l, 2 and 3 of glutamate. 
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Figure 1. The Krebs Cycle 
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If pyruvate-2-c14 is metabolized via acetyl-CoA, the carboxyl car-
hon of acetyl-CoA will be labeled. Consequently carbon 5 in glutamate 
will be labeled (7,8) by the conversion of pyruvate-2-c14 to acetyl-
1-c14-CoA. Labeling in carbon 3 of glutamic acid will result from the 
conversion of pyruvate-2-c14 to a dicarboxylic acid via carbon dioxide 
fixation (7, 8) . The presence of isotope in carbon 2 indicates the 
randomization of pyruvate-2-c14 through fumarate during the formation 
of noncarboxyl-labeled dicarboxylic acid. Carbon 1 of glutamate can be 
labeled from carbon 5 and carbon 2 only after the decarboxylation of 
ketoglutarate to succinate, leading to carboxyl-labeled oxalacetate. 
This resul ts in labeling in carbon 1 to an extent not greater than one-
half that of carbon 5 plus carbon 2 (9, 10). Carbon 1 of glutamate may 
also be labeled by carbon dioxide fixation of bicarbonate-cl4 to yield 
carboxyl-labeled dicarboxylic acid (11, 12). 
The presence of radioactivity in carbon 4 of glutamate after admin-
istration of pyruvate-2-c14 or alanine-2-cl4 can be explained in at 
least two ways. The first is the formation of acetyl-l,2-c14-CoA as a 
product of two sequential decarboxyl~tvns of noncarboxyl-labeled di-
carboxylic acid (7, 8) formed during the equilibration of pyruvate-2-
c14 with fmiarate. Recently, Potanos, Freedman and Graff (13) have ob-
served an unusually high labeling in carbon 4 of brain glutamate after 
the administration of alanine-2-c14 to rats. Because of this observation 
these workers proposed that brain has an unusually active "carbon metabo-
lism" which caused the high labeling in carbon 4 of brain glutamate. 
They suggested that the rapidity of the serine-glycine interconversion 
permits pyruvate-2-cl4 to act as a source of glycine-2-c141 serine-2-cl4, 
4 
formate-c14 and acetate-2-c14 , all potential sources of acetyl-2-c14coA. 
The results to be reported here do not support the hypothesis of Potanos 
et al. (13) • 
The second mechanism involves the formation of glucose-l,2,5,6-c14 
from pyruvate-2-cl4 prior to its utilization by some organ(s). During 
the synthesis of gl9cogen from labeled lactic acid (14), pyruvic acid 
(15) and propionic acid (16) extensive randomization of carbons 2 and 
3 of these acids has been observed. An interesting measurement was 
14 
made by Topper and Hastings (17), with the help of C -labeled substrates, 
of the relative proportion of pyruvate molecules which enter "the shut-
tle" before phosphorylation compared with those that are phosphorylated 
directly. They concluded that "the dicarboxylic acid shuttle is quanti-
tatively a very important intermediate pathway." About 4 pyruvate mole-
cules out of 5 are phosphorylated only after "shuttling." In other 
words the majority of the pyruvate molecules that are converted into 
liver glycogen pass through the c4-dicarboxylic acid stage. Lorber and 
his associates have s·hown that analogous considerations also apply to 
the conversion of lactate (14) and propionate (16) into liver glycogen 
in the rat. These authors fed various isotopic forms of lactate to rats 
and studied the isotopic distribu tion in glucose prepared from liver 
glycogen. They concluded that less than one-sixth of the lactate could 
have been converted to glycogen by a direct reversal of the reactions 
of glycolysis. The data suggest that the bulk of the lactate passes 
through reactions which cause randomization of the isotope between the 
cl and p carbon atoms. A pathway in which such randomization is accom-
plished would be conversion to pyruvic acid, carboxylation to oxalacetic 
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Figure 2. Pathway of synthesis of 
phosphopyruvate. 
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acid and reduction of the latter to fumaric acid. 
It should be emphasized, however, that the formation of the dicar-
boxylic acid is probably not the result of a shuttle but of a one-direc-
tional pathway involving the stages shown in Figure 2. Krebs proposed 
that when the thermodynamic properties of the system are considered, the 
thermodynamic equilibrium of carbohydrate fermentation is very unfavor-
able for a reversal (16). An important contribution was made by Utter 
and Kurahashi (19) who showed con~lusively that pigeon liver possesses 
2 different mechanisms for carbon dioxide fixation. One involves the 
malic enzyme (20) and requires TPN but not ATP. The other involves the 
phosphoenolpyruvic-carboxykinase and requires ATP but not TPN. 
14 Thus glycogen formed from pyruvate-2-C should produce blood glu-
14 
cose-1,2,5,6-C which, if it is metabolized extensively by other tis-
sues, will yield pyruvate-2,3-c14, acetyl-l,2-c14 , and a high labeling 
in carbon 4 of glutamate (21), 
B. The Effect .Qi Ethionine .Q.ll Lipid Metabolism 
I n 1938, Dyer (22) reported that ethionine CS-ethyl homocysteine). 
when administered in a 5 per cent casein diet to young rats, induced a 
r api d l oss in animal weight and death. The simultaneous presence of 
equivalent amounts of ethionine and methionine in the diet prevented 
this loss in weight and no death occurred during the experimental period. 
She concluded that ethionine could not be utilized by the rat in lieu 
of methionine because no metabolic deethylation of ethionine to homo-
cysteine took place. 
In 1941, Harris an d Kohn (23) observed in~. coli a growth inhibi-
tion effect produced by ethionine. This was completely reversed by 
7 
methionine at one tenth the concentration of ethionine in the medium. 
These experiments furnished the basis for .t ,he:; c;once:pt. t hat· ethfonine. 'is an 
antimetabolite of methionine. 
In 1950, when Farber, Simpson and Tarver administered ethionine 
intraperitoneally to fasted female rats, this analogue of methionine was 
found to produce a moderate rise in the lipid, content of the liver with-
in 12 hours and a more marked rise in 24 to 48 hours (24). It has been 
reported by several workers (25, 26) that the fatty infiltration caused 
by ethionine could be prevented by methionine or choline. Salmon and 
Copeland reported that the antagonistic action of methionine or choline 
against ethionine was synergized by vitamine s12 (26). According to 
these workers methionine acted as a methyl donor for the synthesis of 
choline. However, choline has been found to be ineffective in prevent-
ing the rise in liver lipid, caused by an intraperitoneal injection of 
ethionine to fasted rats (24, 27). Artom has found that in livers of 
fasted rats injected with a large dose of DL-ethionine, the increases 
in neutral fat were not accompanied by any decrease in the level of 
choline-containing or total phospholipides. This led to the conclusion 
that the fatty infiltration of the liver is not due to the rapid de-
velopment of a choline deficiency. However, after prolonged adminis-
tration of ethionine in the diet, the production of a chronic choline 
deficiency has been demonstrated (25, 26). 
The influence of hormones upon the development of fatty livers has 
been studied by several workers (24, 28, 29, 30) • Farber et al. (24) 
reported that excess fat accumulation was observed only in female rats. 
Castration made the male animal susceptible. Administration of testos-
terone protected the castrated males while adrenalectomy prevented fat-
ty livers in females. 
Stekol and Weiss have investigated the possibility of deethylation 
of ethionine in the intact rat by administering ethionine which was la-
beled with either s35 of with cl4 in the methylene carbon of the ethyl 
group (31). They isolated radioactive choline and creatinine from the 
tissue of rats which were given c14 ethionine. The activity from the 
methylene carbon was found only in the trimethylamine moiety of the 
choline molecule. These workers isolated radioactive p-bromophenyl mer-
, . d f I . f l . h . d s35 h · . d captunc ac1 · rom t 1e urine O" rats w:nc rece1 ve : -et 1onine an · 
bromobenzene. This indicated that ethionine sulfur was available to 
the rat for cysteine synthesis. 
Recently Artom (27) has demonstrated the effect of ethionine on 
fatty acid metabolism. He observed that homogenates of livers from 
ethionine-treated female rats exhibited a very considerable decrease 
in their ability to oxidize stearate-1-c14 as compared to homogenates 
of normal liver. These homogenates also had a decreased ability to 
oxidize shorter fatty acids, acetate and pyruvate. 
C. Scope of the Problem 
In order to observe how the disturbance of lipid metabolism in 
ethionine-treatecl rats affects the routes of pyruvate metabolisrr~ py-
ruvate-2-c14 was administered to ethionine-treated animals and the radio-
activity of carbon 5 of the muscle and liver glutamic acid was determined. 
The radioactivity of carbon 5 of glutamate reflects the relative amounts 
of pyruvate converted to acetyl-CoA and oxalacetic acid. Assuming no 
variation in pool sizes (7) the results indicate that the abnormal lipid 
9 
metabolism caused by ethionine does not greatly alter the routes of py-
ruvate metabolism. 
The metabolism of pyruvate in rat brain has been studied in order 
to determine whether the reported (13) unusual metabolism of this com-
pound by brain results from the blood-brain barrier (32, 33) or whether 
this is due to a peculiarity of brain tissue. The labeling patterns in 
brain glutamate have been determined after the administration of pyru-
vate-2-c14 and glucose-2-c14 to rats. A finding of high activity in 
f f 14 carbon 4 o brain glutamate o · adult rats given pyruvate-2-C would 
be consistent with the results observed by Potanos et al. (13). 
If the administered pyruvate-2-cl4 was metabolized directly in the 
brain with out prior conversion to other radioactive compounds, the la-
beling in carbon 4 of brain glutamate of rats receiving glucose-2-cl4 
should be similar to that of rats receiving pyruvate-2-c14 • However, 
the finding of a very low activity in carbon 4 of the brain glutamate 
obtained from the animals given glucose-2-c14 would suggest that glu-
cose-2-c14 was absorbed directly by brain whereas pyruvate-2-c14 was 
converted to glucose-l,2,5,6-c14 prior to its entry into brain. The 
data to be reported support the latter proposal. 
In order tO further study the effect of the blood-brain barrier on 
glutamate labeling patterns in brain, young rats were given pyruvate-
2-cl4. 
10 
· CHAPTER II 
EXPERl~TAL 
In the experiments on fatty liver, young female rats weighing 100 
to 150 gm. were used. In the experiments on brain, male rats weighing 
300 to 380 gm. were used. Rats 154 and 163 were eight days old. The 
radioactive metabolite to be given was dissolved in about 1 ml. of 0.9 
per cent saline and injected intraperitoneally. After the injection, 
the animals were placed in a glass metabolism cage which was swept 
with air. The exhaled carbon dioxide was trapped in IN sodium hydrox-
iae for half an hour in the fatty liver experiments and for one hour 
in the brain experiments. All the animals were sacrificed by a blow 
on the head. Rats 130, 137 and 150 were anaes.thesized with ether prior 
to sacrifice. The liver and muscle were isolated from the fatty liver 
animals. Brain was isolated by opening the top of the skull with the 
aid of a forceps and was blotted to remove most of the blood. Table I 
summarizes the individual experiments which were performed. 
Development of .lb£ Fatty Liver .QI DL-Ethionine 
Fatty liver was induced by intraperitoneal injection of ethionine 
as described by Chaikoff and Tarver (34). 
Young female rats (34) weighing 100 to 150 gm. received four in-
traperitoneal injections, at 2.5 hours intervals, of 50 mg. (0.33 m 
moles) of DL-ethionine in 2 ml. of warm saline solution per 100 gm. of 
11 
TABLE I 
A SUMMARY OF THE EXPE_RIMENTS 
Pretreatment Compound 14 .% Exhaled Rat Rat uc of. C 
No. Weight of Animal Injected Injected as cl402 
117 110 Normal Pyruvate 69.7 25 
-2-cl4 
118 145 n " 43.5 34 
ll9 138 Ethionine .. 51.8 10 
126 116 " " 47.4 8 
123* 100 **E + Glucose .. 63 20 
124* 114 " " 50.2 8 
130 125 **F, 24 Hours .. 55.3 5 
137* 122 F + Glucose .. 59.8 28 
145° 301 F, 48 Hours .. 88.l 13.5 
146° 341 " •• 128.5 16 
154() 11.5 Normal " 32 23.1 
163° 19.2 .. .. 18.2 19.9 
148° 313 " Glucy!e 74.2 17 
150° 
-2-C 
347 .. .. 37 19 
158° 122 .. Acetate 128 61.5 
152° 
-1-cl4 
380 " DL-Glutamic 49.5 6.5 
Acid-2-cl4 
*Hats 1230 124 and 137 were given 2 gm. of glucose by stomach 
tube 30 minutes before the injection of pyruvate-2-cl4. 
0 Brain was isolated one hour after the injection of labeled com-
pounds and liver and muscle were isolated from the Rats 
137 30 minutes after the injection of pyruvate-2-cl4. 
117 through 
**E = Ethionine F = Fasted 
12 
body weight. After the first injection food was removed for the dura-
tion of the experiment. The animals seemed nervous and sensitive to 
environmental noise after the second injection and chose to hide at 
the corner of the cage. The animals seemed to be even more nervous 
after the fourth injection. At the end of 24 hours the animals, which 
had lost about 10 to 15 gm. of their body weight, were given sodium 
pyruvate-2-c14 • Without exception the livers of the animals which re-
ceived ethionine were yellow. 
Isolation of Glutamic Acid from ili Muscle and Liver of .Bs..u ill 
Through 137 
After the removal of the liver, head, feet,viscera, lungs, heart 
and skin, a protein powder was prepared 01, 35). from the remaining. muscle 
and skeleton. Th is will be referred to as muscle protein hereafter. 
Glutamic and aspartic acids were isolated from this protein ac-
cording to the methods previously described (35). 
Isolation of Glutarnic ~ J!ll.Q Alanine from ili Brain of .B.s!.§ 145 and 
146 
Brains were removed immediately after sacrifice and weighed. The 
brain protein was obtained by the method previously described for 
muscle and liver (11). 
Five hundred mg. of L-glutamic acid, 250 mg. of alanine and 50 mg. 
of cycteine were added as carrier before the brain protein of Rat 146 
was hydrolyzed. Thi s hydrolysate was combined with that of Rat 145 
for the isolation of glutamic acid and alanine as previously described 
(11 V 35) o 
The specific activity in the brain protein glutamate was estimated 
by assuming that 1 mmole (15 per cent) of glutamic acid was present in 
13 
a gram of brain protein. The estimated specific activity and dilution 
factors are shown below: 
Rat Weight of Weight of , mmoles Dilution Specific Specific 
No . Brain Protein of Factor Activity Activity 
(gm.) (gm.) Carrier mµc/ Illnole ~~c/mmole 
(Diluted) (Undiluted) 
145 1.9 0.267 
3.4 8 .1 10.5 85 
146 1. 77 0.213 
Isolation of Glutamic Acid and Alanine from Whole Brain Tissue of 
Rat 148 
Whole brain tissue hydrolysate was prepared as described by Freed-
man and Graff ( 8) . Whole brain tissue was homogenized with 5 ml. of 
1 N hydrochloric acid for 2 minutes and diluted with 10 ml. of 5 N 
hydrochloric acid and 5 ml. of concentrated hydrochloric acid to make 
a volume of 5 N hydrochloric acid 20 times the original weight of tis-
sue. The solution was transferred to a flask to which 500 mg. of L-
glutamic acid, 250 mg. of alanine, and 20 mg. of cysteine were added 
as carrier. The cysteine was added to make the sharp band on the IR-
120 column which was used as an indicator of amino acid movement. 
The solution was then heated under a reflux for 24 hours. The hu-
min was removed by filtration with 1 to 2 gm. of Celite. The filtrate 
was concentrated to 25 ml. in vaccuo and extracted 3 times with 20 ml. 
portions of amyl alcohol to remove lipids • . The residual amyl alcohol 
was removed with 20 ml. of ethyl ether and glutamic acid and alanine 
were isolated as previously described (ll, .35). 
The specific activity in the whole brain glutamate was estimated 
as follows: it was assumed that one gram of brain contained about 0.13 
14 
gm. of protein (estimated from Rats 145 and 146) and 10 ).lmoles of free 
glutamate (33). The calculated data are as follows: 
Rat Weight moles :µmoles mmoles.· .. Di.lu.tioil Specific Specific 
No. of of of of Factor Activity Activity 
Brain Protein Free Carrier mµc/mn1ole . ~c/mmole (gm.) Glutamic Glutamic (Diluted) (Undiluted) 
148 1.37 178 13 •. 7 3.4 18. 7 133 2490 
Isolation .2! ~ Glutamate llQ.!!! the Brain of Rats 150, 154, 163, 158 
and 152. 
Brain tissue was homogenized with 1.3 ml. of 0.6 N perchloric acid 
per gram net weight of tissue (36). The homogenate was centrifuged for 
10 minutes. The protein precipitate was rehomogenized with a volume of 
0.33 N perchloric acid equal to that of the first supernatant solution 
and centrifuged. The supernatants were combined, neutralized with 2 N 
potassium hydroxide and allowed to stand overnight in the refrigerator. 
The solution, whose volume was about 5 ml., was centrifuged to remove 
the precipitate (KC104). Three millimoles of carrier L-glutamic acid 
were added, the pH of the solution dropping to about 4. The solution 
was warmed for a few minutes and then allowed to cool at room tempera-
ture. An equal volume of 95 per cent ethanol was then added to the so-
lution and glutamic acid was allowed to precipitate overnight in the 
refrigerator. Glutamic acid was removed by filtration and washed with 
5 ml. of absolute ethanol and ether. The yields were usually about 90 
to 100 per cent. 
Glutamic acid was dissolved in 5 ml. of water and a few drops of 
2 N hydrochloric acid, qlld the solution was warmed on the steam bath 
15 
for a few minutes. Aqueous pyridine (25 per cent) was added dropwise 
to the warm solution to bring the pH up to 3.5 and the solution was 
allowed to cool for 10 minutes at room temperature. Then an equal vol-
ume of 95 per cent ethanol was added, and glutamic acid was allowed to 
crystallize overnight in the refrigerator. Constant specific acitvity 
was usually obtained by the second recrystallization. The yields after 
the second recrystallization were approximately 70 per cent. 
This procedure is an elegant one for obtaining free glutamic acid 
from brain. 
The specific activity in the free glutamate of brain was estimated 
according to the data given by Tower (33) • 
Rat Weight of pmoles mmoles Dilution Specific Specific 
No. Brain of Free of Factor Activity Activity 
(gm.) Glutamate Carrier ITl,UC/ IllnO le ll}UC/mmole 
CDi luted.) CUndi 1 u tecl) 
150 1.68 16.B 3.4 202 45.5 9200 
154 0.52 5.2 1.0 192.5 42.6 8200 
163 0, 71 7.1 2.0 282 44.7 12605 
158 1.52 15.2 1.5 98.6 2.2 217 
152 1.26 12.6 1.0 79.5 1.1 825 
Decarboxylation of Glutamic Acid .bl. the Schmidt Reaction 
Carbon 5 of glutamic acid was determined directly by treating this 
amino acid with hydrazoic acid to give carbon 5 as carbon dioxide (39). 
and r).., r~diaminobutric acid. The latter was isolated as the dipicrate 
by a method similar to that described by Adamson (37). The values ob-
tained for carbon 5 by this method were fairly consistent with those 
16 
obtained from Schmidt reactions on butyric acid during the complete de-
gradation of glutamic acid (39, 40 • .Iii_gure 3 represents the Schmidt re-
action apparatus. 
0.68 ,nunoles (100 mg.) of glutamic acid were placed in a 15 ml. 
pear shaped flask (A), and O. 75 ml. of 100 per cent (37) sulfuric acid 
was carefully added. The flask was then stoppered with a glass stopper 
and warmed over a small flame to dissolve the amino acid. The solution 
was chilled in an ice bath for 15 minutes. Three: mmoles (about 200 
mg.) of sodium azide were added to the chilled solution and the reaction 
flash was quickly connected to a distillation head (B) through which ran 
a long air inlet tube (C) equipped with.Ji stopcock. The air inlet tube 
was attached to the head by means of a:short length of tygon tubing (D). 
A side arm from the head was coupled b;\means of a semi-ball joint to 
a fritted glass bubbler containing 5 ml. of 5 per cent acid permangan-
ate CE) to trap sulfur dioxide formed by the reduction of sulfuric acid 
by hydrazo.ic acid. 'I'he permanganate bubbler (E) was attached, by means 
of semi-ball join ts (.~) to a. second fri t ted glass bubbler (G) containing 
5 ml. of carbon dioxide-free 1 N sodium hydroxide. The alkali bubbler 
was attached to a water pump by which the system was evacuated. When 
a fine stream of bubbles was observed in the sodium hydroxide trap the 
reaction flask was slowly warmed by immersing in a water hath which was 
heated so that the temperature of water reached 50° C. in 30 minutes. 
If the reaction became too vigorous at the beginning the water bath was 
removed temporarily. After the evolution of carbon dioxide ceased the 
water bath was raised to boiling and kept there for an hour. At the end 
of this hour, the solution was clear. The stopcock of the air inlet 
tube was opened and carbon dioxide-free air (I) was swept through the 
l 
A 
F 
E G 
· 17 
water 
aspirator. 
Figure 3. The,Apparatus·U.sed in Degrading Glutamic. Acid 
.:;;.,. 
10 
system for a period of an hour. During this time the reaction flask 
was heated in the boiling water bath. At the end of this period, the 
contents of the alkali bubbler were transferred to a Van Slyke appara-
tus for the manometric determination of co2 and subsequent c14 assay 
(38). The yields of carbon dioxide were 80 to 90 per cent. 
Preparation of o( 0 ,r-Diaminobutyric Acid Dipicrate 
The solution remaining after the Schmidt reaction on glutamic acid 
was dissolved in 3 to 4 ml. of water and transferred to a 50 ml. beaker. 
The solution was then neutralized to pH 6 with hot saturated barium 
hydroxide solution and the barium sulfate was removed by centrifuga-
tion. 1'he supernatant was filtered and concentrated to 7 to 10 ml. on 
the steam bath. After the addition of 300 mg. (1.33 mmoles) of picric 
acid the solution was warmed untH all the picric acid was dissolved. 
Some of solutions were allowed to cool at room temperature to crystal-
lize the dipicrate of d.. ,r-diaminobutyric acid. When no crystals formed 
at room temperature, the solutions were left overnight in the refrigera-
tor. The dipicrates were removed by filtration, washed with 2 to 3 
ml. of water, and recrystallized from 5 to 8 ml. of hot water. The 
dipicrates were recrystallized until their melting points reached 180° 
to 183°. 
Deqradation of Glutamic Acid 
The degradation of glutamic acid was accomplished by the method of 
Mosbach 0 Phares and Carson (39 0 40, 41) as modified by Koeppe and Hill (12). 
Usually 2 . mmoles of glutamic acid were used. The series of reactions 
is summarized in Figure 4. 
Ninhydrin 
1 COOR 
I 
2HCNH2 
I Chloramine-T 
3 CH2 
I 
4 CH2 
I 5 COOR 
1 CO2 
+ 
2HC=O 
I 
3 CR2 
I 
4 CH2 
I 
5 COOR 
1 CO2 
+ 
2RC=O 
I N2H4 
2,,CH3 I ... HNs 2 CHs I . 
3 CR2 
I 
4 yR2 
5 COOR 
5 CO2 
---"4) ::5 .CH2 
I 
:4 CR2 
I 
•5 COOR 
-----) 3 CH2 I 
4 CH2 
I 
NH2 
+ 
Figure 4.. The Degradation of Glutamic Acid 
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Degradation of Alanine 
The degradation of alanine was carried out as described by Koeppe, 
Minthorn and Hill (42). 
Carbon Analysis and Hadioacti vity Assa,Y 
The total carbon content of the various compounds was determined 
by the macrocombustion method of Van Slyke and his coworkers (43). 
Carbon dioxide liberated during degradation procedures was also measured 
manometrically. 
The carbon dioxide from the wet combustion of samples and from the 
various degradations was swept into a 28() ml. Borkowsky (44) ionization 
chamber and assayed with a vibrating reed electrometer (45). 
CHAPTER III 
RESULTS 
A summary of the experi ments is presented in Table I . The glutamic 
acid labeling pat terns ar e presented in Tables II, III and IV. In these 
tables , the specific activi ties are expressed as millimicrocuries per 
millimole. The specific activities reported for the liver and brain 
amino acids have been corrected for dilution with carrier during their 
isolation (see Experimental). 
It i s of interest to notice that the rate of c14o2 excretion by 
the normal rats is much faster than by the ethionine-treated and fasted 
animals. Feeding glucose to both animals (ethionine-treated and fasted) 
enhanced t he c14o2 excretion. 
Labeling Patterns i n Glutami c Aci d of Muscle after Administration of 
Pyruvate-~-c14 
As shown i n Tabl e . 11 , .approximately .. 50 per cent of t he total 
radioactivity is located i n carbon 5 of mus~le glutamate of normal rats. 
The labeling in carbon 5 of muscle glutamate is very similar to that of 
skeletal muscle glutamate of normal rats which had received alan i ne-2-
c14 (46). In the glutamate of ethionine-treated animals, about 12 to 
25 per cent of total activity was located in carbon 5 (Rats 119 and 
126). The labeling in carbon 5 of muscle glutamate of fasted animal 
is about 22 per cent of the total activity (Rat 130). This is slightly 
greater than th at of carcass glutamate of male rats which were fasted 
for 4 8 hours prior t o the injection of pyruvate-2-c11, as previously 
.{ 
reported by Koeppe , Mourki des and Hill ( 7). 
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As shown in Table II, the injection of glucose by stomach tube 
prior to the administration of pyruvate-2-cl4 to fasted and ethionine-
treated rats markedly increased the radioactivity of carbon 5 of glu-
tamate. The effect of prior treatment with glucose seems to be greater 
.. 
in the fasted rats than in the ethionine-treated animals. 
Labeling Patf~rns in Glutamic Acid of Liver after Administration of 
Pyruvate-l-L 
Table III summarizes the results obtained from liver glutamate 30 
minutes after administration of pyruvate-2-c14 . In the liver of nonnal 
animals, about 20 per cent of the total radioactivity was located in 
carbon 5. The percentages of activity in carbon 5 of liver glutamate 
from both fasted and ethionine-treated animals are less than 7. As in 
the case of muscle, administration of glucose by stomach tube increased 
the activity in carbon 5 of glutamate isolated from both fasted and 
ethionine-treated rats. 
Labeling Patterns in. Glutamic Acid .su. Brain after Administration .su. 
Labeled Compounds 
The labeling patterns of brain glutamate are summarized in Table 
IV. The results obtained from Rats 145 and 146 are quite consistent 
with those of Potanos, Freedman and Graff (13) . who used alanine-2-c14• 
About 50 per cent of the total radioactivity is located in carbons 5 and 
4 of Rats 145 and 146. It should be noted that more than 15 per cent 
of the activity is located in carbon 4. The ratio of the activity be-
tween the two carbons is approximately 2. In the brain glutamates of 
14 Rats 148 and 150, which were given glucose~2-C , more than 80 per cent 
of total activity was found in carbons 5 and. 1. It is of importance to 
point out that less than 3 per cent of the total activity was located 
in carbon 41 while 55 per cent was in carbon 5. 
It should be noted that the radioactivity in carbon 4 of the brain 
glutamate isolated from young animals (Rats 154 and 163) given pyt11vate-
2-c14 is much less than that of the adult brain glutamate. Also the 
radioactivity in carbon 1 of both young brain glutamates is greater 
than in carbon 5. About 60 to 70 per cent of total activity was found 
in carbons 1 and 5 of the brain glutamates. 
In the animals which were given acetate-1-c14 and glutamic acid-
2-c14, brain glutamate had a very low specific activity (Rats 158 and 
152). As shown in Table IV the activity in carbon 1 is much greater 
than in carbon 5 (Rat 15t). These results are different from those ob-
tained by other workers ( lZ 47, 48, 49), who have shown that the admin-
istration of carboxyl-labeled acetate to rats results in ratios of 
radioactivity of carbon 5 to carbon 1 in liver and carcass glutamate 
which approach a theoretical value of 2. 
The finding of 45 per cent of the total activity in carbon 1 of 
. 14 
brain glutamate (Rat 152), upon administration of glutamic acid-2-C 
is in sharp contrast with the results of Wilson and Koeppe who reported 
that about 20 per cent of the activity of liver and carcass glutamates 
was located in carbon 1 (50) • 
Rat 
No. 
117 
118 
119 
126 
123 
124 
130 
137 
TABLE II 
LABELING PATTERNS IN MUSCLE GLUTAMATE AFTER 
ADMINISTRATION OF PYRUVATE-2-c14 
Pretreatment Total Per cent of total in 
of animal mµc/mmole 1 through 4 
Normal 55 48 
Normal 28 49 
Ethionine 11 79 
Etb.ionine 10 83 
Ethionine + Glucose 34 70 
Ethionine + Glucose 21 64 
Faster., 24 hours 12 74 
Fasted+ Glucose 38 49 
24 
carbons 
5 
49 
47 
26 
12 
36 
30 
22 
48 
Rat 
No,. 
117 
118 
119 
126 
123 
124 
130 
137 
TABLE III 
LABELING PATTERNS IN LIVER GLUTAMATE AFTER 
ADMINISTRATION OF PYRUVATE-2 ... c14 
Pretreatment Total Per cent total 
of animal mµc/mmole 1 through 4 
Normal 414 79 
Normal 215 79 
Ethionine 204 95 
Ethionine 202 97 
Ethionine + Glucose 120 82 
Ethionine + Glucose 241 90 
Fasted, 24 hours 341 90 
Fasted+ Glucose 309 65 
25 
in carbons 
5 
20 
20 
7 
3 
18 
11 
2 
24 
TABLE IV 
LABELING PATTERNS IN BRAIN GLUTAMATE°*' 
Rat Compound Total Per cent of total in carbons 
No. injected mµc/mmole 1 2 3 4 5 
145a Pyruvate-2-C14 
146a 
85 18,.8 15.7 15.9 15.7 33.0 
Pyruvate-2-C14 
154b Pyruvate-2-C14 8200 30•5 19.3 6.6 29,.6 
163b Pyruvate-2-ci4 12605 37.8 lost 8 .. 8 6.7 33.2 
148c Glucose-2-C14 2490 28 .. 0 4.4 5.8 2.4 55.0 
150c Glucose-2-C14 9200 25.7 2 .. 9 5.9 2.4 55.5 
158c Acetate-l-C14 217 51.0 32.8 
152c Glutamic Acid-
2-ci4 825 45.t5 
"*Protein glutamate was pooled from Rats 145 and 146, whole 
(protein plus free) glutamate from Rat 1481 and free glutamate from 
Rats 154, 163, 158 and 152. 
~asted 48 hours before administration of pyruvate-2-C14• 
b 8~day-old rats were used,. 
C Normal adult rats were used. 
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CHAPTER IV 
DISCUSSICN 
The presence of a larger amount of radioactivity in carbon 5 of 
muscle glutamate of normal rats than that of liver glutamate, an obser-
vation similar to those made by Koeppe and his coworkers (7), and 
Freedman et al. (8), may indicate that pyruvate is more extensively 
converted to acetate by muscle than by liver tissues. However, this 
explanation may be incorrect since the acetyl-CoA and the dicarboxylic 
acid pool sizes of the individual tissues are not known. 
The effect of ethionine treatment on the activity of carbon 5 of 
muscle and liver glutamates appears to be the same as that of fasting. 
If the acetyl-CoA and dicarboxylic acid pool sizes do not vary exten-
sively the presence of low activity in carbon 5 of the muscle and liver 
glutamates of fasted and ethionine-treated rats indicates that under 
these conditions of treatment, pyruvate is metabolized less extensively 
to acetate than in the normal animal. Since the development of fatty 
liver with ethionine required fasting it was necessary to examine the 
effect of glucose on the pyruvate metabolism in fasted and ethionine-
treated rats. As shown in Tables II and III, the administration of glu-
cose raised the activity in carbon 5 of both muscle and liver glutamates 
of fasted and ethionine-treated rats. 
If the assumption that glutamate labeling patterns reflect pyruvate 
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metabolism is a correct one and if one ignore~ the :possibility of ~iiked 
variation in pool sizes, the results presented here suggest that the 
gross disturbance in lipid metabolism of the ethionine-treated rats does 
not greatly alter the routes of pyruvate metabolism. 
The finding of a high activity in carbon 4 -Of the brain glutamate 
isolated from Rats 145 and 146, which were fa sted prior to the adminis-
tration of pyruvate-2-c14, is consistent with the observation by Potanos, 
Freedman and Graff (13), who used alanine-2-c14 . As discussed in the 
Introduction, labeling in carbon 4 may be explained in at least t wo ways. 
One mechanism involves the formation of acetyl-1,2-CoA by the double de-
carboxylation of noncarboxyl-labeled oxalacetate after equili bration 
of pyruvate-2-cl4 with a symmetrical dicarboxyli c acid (fumaric). An-
other plausible mechanism involves the formation of glucose-l ,2,5,6-c14 
from pyruvate-2-c14 prior to its entry into brain, presumably as a result 
of the peculiarity of the blood-brain barrier. Subsequently the labeled 
glucose will yield pyruvate-2,3-c14 in the brain which , in turn will give 
a considerable labeling in carbon 4 of brain glutamate. The finding of 
a very small amount of radioactivity in carbon 4 of the brain glutamate 
of animals given glucose-2-c14 strongly suggests that this glucose was 
absorbed directly by the brain and converted to pyruvate-2-c14 which 
gives a low activity in carbon 4. The results obtained with glucose-2-
c14 clearly support the second explanation (above) for the labeling pat-
terns observed in brain glutamate after giving pyruvate-2-c14 or alanine-
2-c14 (13). Potanos, Freedman and Graff proposed that the brain has an 
unusually active "carbon metabolism" (presumably they meant this to read 
"one carbon metabolism") which caused the high labeling in carbon 4 of 
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brain glutamate. The se authors suggested that a rapid serine-glycine 
interconversion permits pyruvate-2-c14 to act as a source of glycine-2-
c14, serine-2-c14, formate-c14 and acetate-2-c14, all capable of forming 
methyl-labeled acetyl-CoA, which will label carbon 4 of glutamate. The 
proposal of a highly active "one carbon metabolism" in rat brain does 
not explain the very low act i vity we have found in carbon 4 of brain 
glutamate isolated from the rats which received glucose-2-c14• There-
fore, the metabolism of pyruvate in rat brain appears to be simil ar to 
its metabolism in other tissues. Blood glucose-I, 2,5, 6-c14 is probably 
formed from pyruvate-2-c14 in the liver and transported across th e blood-
brain barrier to be utilized by brain as an energy source. Thus the un-
usual labeling patterns observed in brain glutamate after the adminis-
tration of alanine-2-c14 (13) or pyruvate-2-cl4 are probably due to the 
metabolism of pyruvate prior to its entry into the brain. 
An interesting observation is that about 55 per cen t of the total 
activity was located in carbon 1 of brain glutamate of the rats given glu-
cose-2-c14 (Rats 148 and 150). Thus brain, like muscle (46), appear s 
to convert a large proportion of its pyruvate to acetate. 
The presence of lower activity in carbon 4 of young rat brain <Rats 
154 and 163) may indicate that the young brain is more permeable to py-
ruvate. It has been shown by Tower (33) that the blood-brain barrier 
is absent or rudimentary in new-born mammal s and becomes active during 
the first few weeks of life. 
The high activity of carbon 1 relative to carbon 2 plus carbon 5 
of young brain glutamates is also of interest. Koeppe_, Hill and Mour-
kides (7), and Freedman and Graff (8) have demonstrated that carbon 1 
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of glutamat es i sol ated from rats given pyruvate-2-c14 is never more t han 
one half that of carbon 2 plus carbon 5. Since theoretically {11) car-
bon 1 should not exceed 50 per cent of carbon 2 plus .carbon ,5, · the label-
ing in carbon 1 of the young brain glu tama tes is diff i cult t o explai n. 
One possibility is that carbon di oxide fi xation i n t he brain from a bi-
carbonate-c14 pool of hi gh speci f ic act i vi ty resulted i n a substantial 
synthesis of carboxyl-labe l ed oxal acet ate, whi ch i n t urn wou ld label 
carbon 1 of glutami c acid {1 2, 51, 52, 53). Recently Berl et al . demon-
strated the ext en si ve participation of carbon dioxide fixation in brain 
metabolism {54) . 
In order to further demonstrate the effect of the blood-brain bar-
rier on glutamat e l abeling patterns in brain, acetate-1-c14 and glutamic 
acid-2-c14 were administered to normal adult rats. The high activity 
of carbon 1 of the brain glutamates from these animals is unusual. If 
acetate-1-c14 or glutami c acid- 2-c14 were taken up directly by brain 
{Rats 152 and 158), the activity in carbon 1 would be expected to be 
about 30 per cent from acetate- 1- c14 {12) and 20 per cent from gl utami c 
acid-2-c14 {50, 55). However , t he fin ding of about 50 per cent of t he 
total activity i n carbon 1 and of a very low total specific acti vi t y in 
the brain glutamate (Rats 152 and 158) suggests that much of t he radio-
activity from acet ate-1- c14 (56) and glutamate-2-c14 entered the br ain 
only after prior convers i on i n the liver to glucose-3, 4-c14• 
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CHAPTER V 
SUMMARY 
Pyruvate-2-cl4 was given to normal, ethionine-treated and fasted 
female rats. Glutamic acid was isolated from muscle and liver. De-
gradation of glutamic acid demonstrated that in normal animals py_ruvate 
was more extensively converted to acetate by muscle than by liver tis-
sue. The degree to which pyruvate is converted to acetate is reflected 
in a direct manner by the exten.t to which radioactivity is incorporated 
into carbon 5 of tissue glutamate. The animals which were either fasted 
or pretreated with ethionine exhibited a markedly lower activity in car-
bon 5 of muscle and liver glutamate. The effect of ethionine on the 
incorporation of activity into carbon 5 of glutamic acid appears to be 
the same as that of fasting since feeding glucose to the fasted and 
ethionine-treated rats markedly raised the activity in carbon 5 of both 
muscle and liver glutamates. 
After administration of pyruvate-2-cl4 to adult and to eight-day 
old rats, and of glucose-2-c14 to normal adult rats, brain glutamate 
was isolated and completely degraded. The presence of approximately 15 
per cent of the total radioactivity in carbon 4 of adult brain glutamate 
of rats receiving pyruvate-2-cl4, and the presence of less than 3 per 
cent of the total activity in carbon 4 of the brain glutamate of rats 
receiving glucose-2-c14, suggests that, in adult rats, pyruvate-2-cl4 
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was converted to glucose-l,2,5,6-c14 prior to utilization by the brain. 
On the other hand, the finding about 6.7 per cent of total activity in 
carbon 4 of the brain glutamate of young rats receiving pyruvate-2-c14 
may indicate that in the young rat more pyruvate was taken up directly 
by the brain. 
Since the above res.ul ts may be explained on the basis of a blood-
brain barrier. acetate-l-c14 and glutamic acid-2-c14 were given to 
adult rats. and the brain glutamates were isolated and degraded. The 
finding of a high amount of activity in carbon 1 of the brain glutamates 
from these animals suggests that much of the acetate-1-cl4 and the glu-
tamic acid-2-c14 was taken up by the brain only after prior conversion 
to blood glucose-3~4-C14 by the liver. 
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